These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2686125)

  • 1. Point mutations may account for pyrimethamine resistance.
    Ash C
    Trends Pharmacol Sci; 1989 Aug; 10(8):303-4. PubMed ID: 2686125
    [No Abstract]   [Full Text] [Related]  

  • 2. The dihydrofolate reductase domain of rodent malarias: point mutations and pyrimethamine resistance.
    Cheng Q; Saul A
    Mol Biochem Parasitol; 1994 Jun; 65(2):361-3. PubMed ID: 7969277
    [No Abstract]   [Full Text] [Related]  

  • 3. A molecular epidemiologic study of point mutations for pyrimethamine-sulfadoxine resistance of Plasmodium falciparum isolates from Lao PDR.
    Toma H; Imada Y; Vannachone B; Miyagi M; Kobayashi J; Uechi G; Pethuvang R; Manivong K; Phompida S; Sato Y
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):602-4. PubMed ID: 16124424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria.
    Peterson DS; Walliker D; Wellems TE
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9114-8. PubMed ID: 2904149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis for pyrimethamine resistance in Plasmodium falciparum.
    Zolg JW; Plitt JR; Chen GX; Palmer S
    Mol Biochem Parasitol; 1989 Oct; 36(3):253-62. PubMed ID: 2677719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.
    Koukouikila-Koussounda F; Bakoua D; Fesser A; Nkombo M; Vouvoungui C; Ntoumi F
    Infect Genet Evol; 2015 Jul; 33():32-6. PubMed ID: 25934142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria.
    Peterson DS; Milhous WK; Wellems TE
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3018-22. PubMed ID: 2183222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fitness effects of DHFR-TS mutations associated with pyrimethamine resistance in apicomplexan parasites.
    Fohl LM; Roos DS
    Mol Microbiol; 2003 Nov; 50(4):1319-27. PubMed ID: 14622418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of molecular markers for resistance to chloroquine and pyrimethamine in Plasmodium falciparum from Zimbabwe.
    Mlambo G; Sullivan D; Mutambu SL; Soko W; Mbedzi J; Chivenga J; Gemperli A; Kumar N
    Parasitol Res; 2007 Sep; 101(4):1147-51. PubMed ID: 17546463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
    Basco LK; Ringwald P
    Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel alleles of Plasmodium falciparum dhfr that confer resistance to chlorcycloguanil.
    Hunt SY; Rezvani BB; Sibley CH
    Mol Biochem Parasitol; 2005 Jan; 139(1):25-32. PubMed ID: 15610816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Field-based evidence for linkage of mutations associated with chloroquine (pfcrt/pfmdr1) and sulfadoxine-pyrimethamine (pfdhfr/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparum.
    Osman ME; Mockenhaupt FP; Bienzle U; Elbashir MI; Giha HA
    Infect Genet Evol; 2007 Jan; 7(1):52-9. PubMed ID: 16690361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of the dihydrofolate reductase Asn-108 mutation as the basis for pyrimethamine-resistant falciparum malaria in the Brazilian Amazon.
    Peterson DS; Di Santi SM; Povoa M; Calvosa VS; Do Rosario VE; Wellems TE
    Am J Trop Med Hyg; 1991 Oct; 45(4):492-7. PubMed ID: 1951858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria.
    Méndez F; Muñoz A; Carrasquilla G; Jurado D; Arévalo-Herrera M; Cortese JF; Plowe CV
    Am J Epidemiol; 2002 Aug; 156(3):230-8. PubMed ID: 12142257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium falciparum: gene mutations and amplification of dihydrofolate reductase genes in parasites grown in vitro in presence of pyrimethamine.
    Thaithong S; Ranford-Cartwright LC; Siripoon N; Harnyuttanakorn P; Kanchanakhan NS; Seugorn A; Rungsihirunrat K; Cravo PV; Beale GH
    Exp Parasitol; 2001 Jun; 98(2):59-70. PubMed ID: 11465989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conflicting requirements of Plasmodium falciparum dihydrofolate reductase mutations conferring resistance to pyrimethamine-WR99210 combination.
    Japrung D; Leartsakulpanich U; Chusacultanachai S; Yuthavong Y
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4356-60. PubMed ID: 17875995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular monitoring of dihydrofolatereductase (dhfr) and dihydropteroatesynthetase (dhps) associated with sulfadoxine-pyrimethamine resistance in Plasmodium vivax isolates of Palawan, Philippines.
    Bareng AP; Espino FE; Chaijaroenkul W; Na-Bangchang K
    Acta Trop; 2018 Apr; 180():81-87. PubMed ID: 29352991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrimethamine resistant mutations in Plasmodium falciparum.
    Thaithong S; Chan SW; Songsomboon S; Wilairat P; Seesod N; Sueblinwong T; Goman M; Ridley R; Beale G
    Mol Biochem Parasitol; 1992 Jun; 52(2):149-57. PubMed ID: 1620155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes.
    Méndez F; Herrera S; Murrain B; Gutiérrez A; Moreno LA; Manzano M; Muñoz A; Plowe CV
    Am J Trop Med Hyg; 2007 Sep; 77(3):438-43. PubMed ID: 17827356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An amino acid substitution in the Babesia bovis dihydrofolate reductase-thymidylate synthase gene is correlated to cross-resistance against pyrimethamine and WR99210.
    Gaffar FR; Wilschut K; Franssen FF; de Vries E
    Mol Biochem Parasitol; 2004 Feb; 133(2):209-19. PubMed ID: 14698433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.